首页> 外国专利> USE OF ANTIESTROGENIC NAPHTYL DERIVATIVES FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR MINIMIZING THE UTEROTROPHIC EFFECT OF TAMOXIFEN AND TAMOXIFEN ANALOGS AND THE COMPOSITIONS

USE OF ANTIESTROGENIC NAPHTYL DERIVATIVES FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR MINIMIZING THE UTEROTROPHIC EFFECT OF TAMOXIFEN AND TAMOXIFEN ANALOGS AND THE COMPOSITIONS

机译:抗雌性萘衍生物在生产药物组合物中的应用,以最小化他莫昔芬和他莫昔芬的类似物的营养作用

摘要

The present invention provides a method of minimizing the uterotrophic effect of non-steroidal antiestrogen compounds of formula II CHEM wherein either R4 is H or a lower alkyl radical and R5 is a lower alkyl radical, or R4 and R5 are joined together with the adjacent nitrogen atom to form a heterocyclic radical; R6 is H or a lower alkyl radical; R7 is H, halo, OH, a lower alkyl radical, or is a buta-1,3-dienyl radical which together with the adjacent benzene ring forms a naphthyl radical; R8 is H or OH; and n is 2; or a pharmaceutically acceptable salt thereof, wherein said formula II compound is administered to a woman for the treatment or prevention of breast carcinoma, comprising concurrently or sequentially administering to said woman a compound of formula I CHEM wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); n is 2 or 3; and R3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. The present invention further provides pharmaceutical compositions comprising a compound of formula I and a compound of formula II together with a pharmaceutically acceptable carrier, excipient, or diluent.
机译:本发明提供了一种使式II 的非甾体抗雌激素化合物的子宫营养作用最小化的方法,其中R 4是H或低级烷基,R 5是低级烷基,或R < 4和R 5与相邻的氮原子连接在一起形成杂环基。 R 6为H或低级烷基。 R 7为H,卤素,OH,低级烷基或为与相邻的苯环一起形成萘基的丁基-1,3-二烯基。 R 8为H或OH; n是2;或其式药学上可接受的盐,其中将所述式II化合物施用于妇女以治疗或预防乳腺癌,包括向所述妇女同时或依次施用式I 的化合物,其中R 1为-H ,-OH,-O(C 1 -C 4烷基),-OCOC 6 H 5,-OCO(C 1 -C 6烷基)或-OSO 2(C 4 -C 6烷基); R 2为-H,-OH,-O(C 1 -C 4烷基),-OCOC 6 H 5,-OCO(C 1 -C 6烷基)或-OSO 2(C 4 -C 6烷基); n为2或3; R 3为1-哌啶基,1-吡咯烷基,甲基-1-吡咯烷基,二甲基-1-吡咯烷基,4-吗啉代,二甲基氨基,二乙基氨基或1-六亚甲基亚氨基。或其药学上可接受的盐。本发明进一步提供了药物组合物,其包含式I的化合物和式II的化合物以及药学上可接受的载体,赋形剂或稀释剂。

著录项

  • 公开/公告号HUT77954A

    专利类型

  • 公开/公告日1998-12-28

    原文格式PDF

  • 申请/专利权人 ELI LILLY AND CO.;

    申请/专利号HU19980001476

  • 发明设计人 BRYANTHENRY UHLMAN;FONTANASTEVEN ANTHONY;

    申请日1995-09-18

  • 分类号A61K31/55;A61K31/535;A61K31/445;A61K31/40;A61K31/21;A61K31/26;A61K31/135;

  • 国家 HU

  • 入库时间 2022-08-22 02:27:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号